edge veterinary vaccines consulting group

What edge veterinary vaccines consulting group does

Edge Veterinary Vaccines Consulting Group (EDGE) is a U.S. private LLC founded in 2013 by three former USDA Center for Veterinary Biologics (CVB) employees — Hans Draayer, Larry Elsken, and Donna Gatewood — to provide regulatory and technical consulting for veterinary biologics. The firm advises companies developing, manufacturing, and distributing veterinary vaccines, antibodies, immunotherapeutics, and diagnostic products regulated by USDA-CVB, with additional working knowledge of the Canadian Centre for Veterinary Biologics and the European Medicines Agency/CVMP frameworks. Services span the full regulatory lifecycle: product development, support of diagnostic product licensing, jurisdictional product review, product life cycle management, quality management and improvement, facility audits, M&A support, label revisions, deviation reporting, advertising review, and personnel training ranging from short overviews to full-day on-site programs.

The team comprises three Partners (Matt Erdman, Paul Hauer, Carolyn Ross), five Senior Consultants (Nancy Clough, Tom Evans, Carol Gibbs, Renee Schnurr, and Statistician/Senior Consultant Chris Tong), one Technical Writer (Kristin Draayer), and the two retired founders (Elsken and Gatewood), collectively representing over 300 years of combined industry and agency experience. Most consultants are former USDA CVB Section Leaders, Reviewers, Inspectors, Risk Managers, or Directors; others held senior roles at major animal health firms including Zoetis, Fort Dodge Animal Health, and Lohmann Animal Health. The firm explicitly positions itself as a translation layer between biologics manufacturers and the regulatory body that licenses their products.

EDGE operates a sales-led, direct-engagement professional services model. Clients initiate projects by contacting partners or the firm directly via email; the website lists contact details for Matt Erdman, Paul Hauer, and Carolyn Ross and a general invoicing inbox. Marketing relies primarily on direct referrals and industry reputation, supported by a professional website that publishes team credentials and curated links to USDA-CVB, CCVB, EMA, and major animal health industry associations. Pricing is not publicly disclosed and is handled on a quote/engagement basis. The firm maintains no software product, no API surface, no patents or trademarks, and no disclosed institutional investment, functioning as a pure expert-advisory consultancy anchored on the personal regulatory experience of its partners and senior consultants.

Name

edge veterinary vaccines consulting group

Legal name

EDGE Veterinary Vaccines Consulting Group, LLC

Website

https://edgevcg.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

1–10 employees

Short description

Edge Veterinary Vaccines Consulting Group is a U.S. regulatory consultancy founded in 2013 by former USDA Center for Veterinary Biologics officials, advising veterinary biologics manufacturers on USDA-CVB product licensing, quality management, inspections, and lifecycle compliance across the U.S., Canada, and the EU.

Ownership category

akta.pro rank

Product category

Veterinary Regulatory Consulting

NAICS

Other Scientific and Technical Consulting Services (54169)

SIC

Services-Engineering, Accounting, Research, Management (8700)

akta.pro primary industry

Regulatory, Health Certificates & Export/Import Compliance (Large Animal/Equine) (HLAMABAL)

akta.pro secondary industry

Veterinary Regulatory Authorities (Licensing, Compliance & Enforcement) (HLAMAJAC)

Keywords

• Veterinary biologics consulting
• USDA-CVB regulatory affairs
• Vaccine licensing support
• Regulatory compliance consulting
• Biological product registration

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Regulatory Consulting Services: Professional consulting services providing regulatory and technical knowledge supporting the production, registration, and distribution of veterinary biologics. Services cover all aspects of regulatory affairs from start-up through product life cycle management, facility audits, and training.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

EDGE provides regulatory and technical consulting services for USDA-CVB regulated veterinary biologics, covering product development, licensing support, manufacturing and quality management, facility audits, lifecycle management, and training. The firm advises veterinary biologics manufacturers on navigating complex regulations for vaccines, antibodies, immunotherapeutics, and diagnostic products from startup through product lifecycle.

Product overview

Edge Veterinary Vaccines Consulting Group is a regulatory consulting firm that provides advisory services for veterinary biologics companies. The company does not offer a software product or platform; instead, it delivers professional consulting services including regulatory support for product development, product life cycle management, quality management and improvement, and training and personnel development for USDA-CVB regulated veterinary biologics. The firm is organized as a team of regulatory consultants rather than a product-based company.

Differentiator

Problem solved

Functional benefit

Products and services

• Regulatory Consulting Services for Veterinary Biologics Professional consulting services providing regulatory and technical knowledge supporting the production, registration, and distribution of veterinary biologics for veterinary biologics manufacturers. Covers all aspects of regulatory affairs from start-up through product life cycle management, facility audits, and training.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Six partnerships are on record, tiered core and minor.

• USDA Center for Veterinary BiologicscoreOthersPrimary regulatory authority governing veterinary biologics in the United States. EDGE maintains deep connections with CVB through its team of former CVB employees who understand policies, procedures, and current thinking on key regulations.
• Canadian Centre for Veterinary BiologicsminorOthersCanadian regulatory authority for veterinary biologics. EDGE provides guidance on Canadian regulatory requirements including memoranda and guidelines.
• European Medicines Agency (CVMP)minorOthersEuropean regulatory body for veterinary medicinal products. EDGE maintains knowledge of EMA guidelines for veterinary vaccines (IVMPs) and GMP requirements.
• United States Animal Health InstituteminorOthersIndustry organization providing resources and guidance for animal health companies in the US.
• United States Association of Veterinary Biologics Companies (AVBC)minorOthersIndustry association representing veterinary biologics companies. EDGE maintains connection as a service provider to member companies.
• Animal Health EuropeminorOthersEuropean industry organization for animal health. EDGE maintains awareness of European regulatory landscape through this connection.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• argenta (formerly KLIFOVET): argenta is an animal health contract research and regulatory services firm offering veterinary biologics development and regulatory support, directly overlapping EDGE's USDA-CVB licensure and product development consulting. Both firms serve veterinary vaccine and biologics manufacturers with regulatory affairs expertise.
• Knoell (formerly Triveritas): Triveritas (now part of knoell) is a veterinary regulatory consultancy specifically focused on animal health product registration in the EU, US, and other regions. Direct competitor to EDGE in biologics regulatory affairs with comparable agency-veteran team pedigree.

Broad incumbents

• NAMSA: NAMSA is a global medical device and animal health regulatory/quality consulting firm with significantly larger scale. Comparable to EDGE in regulatory consulting service delivery but broader in scope (medical devices plus animal health) and with a more global footprint.
• ProPharma Group: ProPharma is a life sciences regulatory, compliance, and quality consulting firm serving pharma, medical device, and animal health clients. Overlaps with EDGE on regulatory affairs consulting but at much larger scale and broader therapeutic scope.
• Parexel International: Parexel is a global CRO with dedicated regulatory consulting services across pharma and animal health. Competes with EDGE for veterinary biologics regulatory work but operates at vastly larger scale with full-service clinical and regulatory capabilities.
• ICON plc: ICON is a major global CRO offering regulatory affairs and product development consulting spanning human and animal health. Comparable to EDGE as a regulatory consulting provider but with broader therapeutic and geographic coverage.
• Zoetis: Zoetis is the world's largest animal health company and a major EDGE client/employer lineage (multiple EDGE team members came from Zoetis or its predecessors). While Zoetis has its own internal regulatory affairs team, it also purchases outside regulatory consulting for specialized projects.
• Elanco Animal Health: Elanco is one of the largest animal health companies globally with internal regulatory affairs capabilities. It is also a potential customer for EDGE's biologics consulting services and a former employer of consulting team members.
• Ceva Santé Animale: Ceva is a major global animal health company with significant vaccine/biologics business and EU regulatory footprint. Represents both a potential customer for EDGE's regulatory consulting and a peer in navigating CVMP/EMA frameworks.
• IDEXX Laboratories: IDEXX is a leader in veterinary diagnostics with companion animal practice software. While not a direct regulatory consulting competitor, IDEXX is an adjacent incumbent in animal health with overlapping biologics-adjacent regulatory exposure.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/edgevcg

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about edge veterinary vaccines consulting group